Ai Fanrong, Ferreira Carolina A, Chen Feng, Cai Weibo
School of Mechanical & Electrical Engineering, Nanchang University, Jiangxi, China.
Department of Radiology, University of Wisconsin - Madison, Madison, WI, USA.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jul;8(4):619-30. doi: 10.1002/wnan.1386. Epub 2015 Dec 22.
Over the last decade, radiolabeled iron oxide nanoparticles have been developed as promising contrast agents for dual-modality positron emission tomography/magnetic resonance imaging (PET/MRI) or single-photon emission computed tomography/magnetic resonance imaging (SPECT/MRI). The combination of PET (or SPECT) with MRI can offer synergistic advantages for noninvasive, sensitive, high-resolution, and quantitative imaging, which is suitable for early detection of various diseases such as cancer. Here, we summarize the recent advances on radiolabeled iron oxide nanoparticles for dual-modality imaging, through the use of a variety of PET (and SPECT) isotopes by using both chelator-based and chelator-free radiolabeling techniques. WIREs Nanomed Nanobiotechnol 2016, 8:619-630. doi: 10.1002/wnan.1386.
在过去十年中,放射性标记的氧化铁纳米颗粒已被开发成为用于双模态正电子发射断层扫描/磁共振成像(PET/MRI)或单光子发射计算机断层扫描/磁共振成像(SPECT/MRI)的有前景的造影剂。PET(或SPECT)与MRI的结合可为无创、灵敏、高分辨率和定量成像提供协同优势,适用于癌症等各种疾病的早期检测。在此,我们通过使用基于螯合剂和无螯合剂的放射性标记技术,利用多种PET(和SPECT)同位素,总结了用于双模态成像的放射性标记氧化铁纳米颗粒的最新进展。《WIREs纳米医学与纳米生物技术》2016年,8:619 - 630。doi:10.1002/wnan.1386 。